Form 4: HealthEquity CTO Sells Shares for Tax Obligations

HealthEquity's Chief Technology Officer, Elimelech Rosner, disposed of 3,006 shares of common stock to cover tax withholding obligations at a price of $88.5674 per share.

Summary

• Elimelech Rosner, Executive Vice President and Chief Technology Officer of HealthEquity, Inc. (HQY), reported a transaction involving company common stock.
• The transaction occurred on October 6, 2025, and involved the disposition of 3,006 shares of common stock.
• The shares were disposed of at a price of $88.5674 per share.
• This disposition was made to satisfy tax withholding obligations, indicated by transaction code 'F'.
• Following this transaction, Mr. Rosner beneficially owns 56,701 shares of HealthEquity common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, pre-planned transaction for tax purposes and does not indicate a change in the executive's confidence in the company or its future prospects.

Negatives

• Disposition of 3,006 shares of common stock by a key executive, though for tax withholding purposes.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine event common across all industries for executives receiving equity compensation, particularly when shares vest and tax obligations arise. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: A minor, routine disposition of shares by an executive, unlikely to have a significant impact on shareholder sentiment or the company's valuation.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned disposition of shares by a company executive to satisfy tax withholding obligations. Such transactions are common and do not typically reflect a change in the executive's long-term view of the company or its fundamentals. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

HealthEquity, HQY, Form 4, Insider Transaction, Elimelech Rosner, Stock Disposition, Tax Withholding, Executive Compensation, 10b5-1 Plan